Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Safety and Effectiveness of Virtual Reality Utilizing RelieVRx for Total Knee Arthroplasty (TKA) for the Reduction of Acute Postoperative Pain and Opioid Use


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT04010266

Organisation Name: AppliedVR Inc.

Overal Status: Not yet recruiting

Start Date: August 1, 2020

Last Update: July 15, 2020

Lead Sponsor: AppliedVR Inc.

Brief Summary: This is a single-center, prospective, randomized, controlled study of the appliedVR RelieVRx headset in subjects undergoing Total Knee Arthroplasty (TKA). This study will evaluate two primary endpoints - effectiveness of a single use of RelieVRx in the reduction of acute postoperative pain by 20%; and overall effectiveness of RelieVRx as an opioid-sparing intervention, where opioid consumption is reduced by at least 20% over a 90-day postoperative period in the interventional, standard of care (SOC) plus RelieVRx group compared to the control, SOC group.

Conditions:
  • Opioid Use
  • Arthropathy of Knee
  • Pain, Postoperative


Total execution time in seconds: 0.19991898536682